Jeffrey Humphrey Lantheus Holdings, Inc. (LNTH) insider trading activity

Jeffrey Humphrey is Chief Medical Officer of Lantheus Holdings, Inc.. Currently has a direct ownership of 9,076 shares of LNTH, which is worth approximately $925,570. The most recent transaction as insider was on Jun 17, 2024, when has been sold 9,076 shares (Common Stock) at a price of $82.63 per share, resulting in proceeds of $749,949. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.08K

n/a 3M change

n/a 12M change

Total Value Held $925,570

Jeffrey Humphrey Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 17 2024	BUY Grant, award, or other acquisition	$749,949 $82.63 p/Share	9,076 Added 50.0%	9,076 Common Stock

Also insider at

CYT

Cyteir Therapeutics, Inc. Healthcare

Director

MGTA

Magenta Therapeutics, Inc. Healthcare

Chief Medical Officer

CNST

CONSTELLATION PHARMACEUTICALS INC Healthcare

Chief Medical Officer